UK government advisers reject calls to introduce a major national prostate cancer screening programme, according to reporting. Prostate cancer is described as the most common cancer among men in the UK. While there are national screening programmes for some other cancers—including breast, bowel and lung—there is currently no comparable national programme for prostate cancer. The discussion centres on whether screening should be expanded and how it could affect early detection and outcomes. Supporters of a programme argue it could identify cancer earlier and prevent avoidable deaths. Critics and advisers are reported to have different concerns about the evidence and potential downsides of screening at a population level, such as balancing benefits against possible harms. The outlets also highlight the scale of the issue by noting that many men could be affected by the lack of a national screening approach. The decision means prostate cancer screening in the UK remains dependent on clinical practice and individual pathways rather than a formal, nationwide screening programme.